International Clinical Trial: A 12-week, single-center, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for improvement of HFN2-017 on muscle strength

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011350) titled 'A 12-week, single-center, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for improvement of HFN2-017 on muscle strength' on Dec. 18, 2025.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(Among adult men and women over the age of 50 to 85, the change in the following evaluation items that appears when 3 capsules are consumed once a day for 12 weeks is compared with the control group), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Huons

Condition:

Not Applicable...